Metraipolis › archive › dc_b3dca09a3e40

Effects of SGLT2 inhibitors on body composition and potential sarcopenia-related outcomes in type 2 diabetes mellitus: a network meta-analysis — Europe PMC PMID:42591093

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42591093
DOI
10.3389/fendo.2026.1877008
License (as archived)
solo-consultazione
Archived
2026-10-17T10:05:36.135Z
SHA-256 of the archived text
864a27c373884a5bc16fe8dcc3f24c99c4f10d0037a2a9d11b5c38b3c505ed18
Stable URL of this page
https://metraipolis.com/documento/dc_b3dca09a3e40

How to cite

Effects of SGLT2 inhibitors on body composition and potential sarcopenia-related outcomes in type 2 diabetes mellitus: a network meta-analysis — Europe PMC PMID:42591093 — Europe PMC (en), https://europepmc.org/article/MED/42591093 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b3dca09a3e40 (Metraipolis archive dc_b3dca09a3e40, sha256 864a27c373884a5bc16fe8dcc3f24c99c4f10d0037a2a9d11b5c38b3c505ed18)
BibTeX
@misc{dcb3dca09a3e40,
  title = {Effects of SGLT2 inhibitors on body composition and potential sarcopenia-related outcomes in type 2 diabetes mellitus: a network meta-analysis — Europe PMC PMID:42591093},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42591093},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b3dca09a3e40; sha256 864a27c373884a5bc16fe8dcc3f24c99c4f10d0037a2a9d11b5c38b3c505ed18},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42591093. Agents can read the archived copy with the MCP tool read_document.